Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

FOLLOW US: 

October 4, 2019

New Plaintiff Fact Sheets Provide Information on Valsartan Cancer Claims

Valsartan Plaintiffs Must Submit Plaintiff Fact Sheet


The judge presiding over all federal valsartan lawsuits now orders each individual valsartan claim to submit a Plaintiff Fact Sheet (PFS) in the valsartan multidistrict litigation (MDL). The Plaintiff Fact Sheet allows valsartan plaintiffs to provide case-specific information about their valsartan cancer diagnoses and exposure.

Currently over 130 valsartan cancer lawsuits and class action claims are pending in the federal court system. These claims are currently centralized in a multidistrict litigation in the District of New jersey before U.S. District Judge Robert B. Kugler.

Each lawsuit raises similar claims that valsartan manufacturers distributed pills contaminated with dangerous probable carcinogens. N-nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA) have been found by the FDA to increase the likelihood of users getting cancer.

Valsartan lawsuits filed across the country claim their use of toxic valsartan pills contributed to their cancer diagnoses. Plaintiffs claim cancers including liver cancer, small intestine cancer, stomach cancer, esophageal cancer, pancreatic cancer, and prostate cancers among others.

Judge Kugler released the PFS update in a case management order released Thursday. Judge Kugler ordered for the use of a PFS to help ease the exchange of information about each valsartan claim. Each individual who has already completed and filed the Short Form Complaint in the valsartan multidistrict litigation must complete a PFS within 90 days. This order includes individuals diagnosed with valsartan-caused cancer, those seeking medical monitoring through class action claims, and individuals claiming other economic losses from valsartan use.

Many anticipate Judge Kugler to establish a “bellwether” trial process as part of the coordinated pretrial proceedings. As part of this process, parties will use the PFS information to select a representative group of valsartan cases. These valsartan lawsuits would be prepared for early trial dates as part of the valsartan multidistrict litigation.

Recent Posts

Uloric Lawsuit Claims Gout Drug Caused Man’s Congestive Heart Failure

A recently filed lawsuit claims the prescription drug Uloric caused a man’s congestive failure and left him with permanent health problems. This lawsuit joins numerous others from across the nation, each raising similar claims that Uloric manufacturers failed to warn the public about the severe side effects of taking Uloric. On August 26, James Wagers, […]

Read More
Elmiron Bladder Medication Caused Woman to Become Legally Blind, Lawsuit Claims

A new product liability lawsuit claims Elmiron bladder medication caused a woman to steadily lose her vision, causing her to be diagnosed as legally blind. This lawsuit joins numerous others from across the U.S., each raising similar allegations that Elmiron’s toxic side effects caused vision injuries including vision loss and blindness. Teresa Townsend, a Wisconsin […]

Read More

Contact Us Today for your free, in-depth case evaluation

We're on Your Side
We're available 24/7
no fees unless you win

Free in-depth 
no obligation case evaluation

envelopeprinterphone-handsetmap-markerarrow-right
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram